CM:TSXCanadian Imperial Bank of Commerce Analysis
Data as of 2026-03-10 - not real-time
CA$132.90
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Canadian Imperial Bank of Commerce (CM) is trading at C$132.9, comfortably above its 50‑day SMA (C$130.3) but below the 20‑day SMA (C$135.0), indicating a short‑term pull‑back within a broader bullish trend. The stock enjoys a solid dividend yield of 3.16% with a modest payout ratio (≈41%), and recent news highlights its appeal as a dividend play. Valuation metrics are attractive – a trailing P/E of 14.1 versus the industry average of 17.4 and an upside potential of roughly 8% to the next resistance level (C$143.8). Operating margins are strong (44.7%) and revenue is growing at 16.7% YoY, though operating cash flow is negative, which warrants monitoring. Overall, the combination of undervalued pricing, steady dividend income, and supportive analyst sentiment (Buy) makes CM a compelling candidate for income‑focused investors, while the technical setup suggests cautious optimism for near‑term price appreciation.
Investors should weigh the modest volatility (≈23% 30‑day) and low beta (~0.42) against the bank’s strong fundamentals and dividend sustainability before positioning.
Investors should weigh the modest volatility (≈23% 30‑day) and low beta (~0.42) against the bank’s strong fundamentals and dividend sustainability before positioning.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 7/10
Key Factors
- Price near technical support at C$128.6
- Strong dividend yield supporting total return
- MACD bearish crossover suggesting limited upside in the next few weeks
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Revenue growth of 16.7% and high operating margins
- Undervalued relative to peers (P/E 14.1 vs industry 17.4)
- Analyst consensus (Buy) and upside potential to C$143.8
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Sustainable dividend backed by strong capital and low payout ratio
- Stable Canadian banking environment with low beta
- Continued earnings expansion reflected in forward EPS and lower forward P/E
Key Metrics & Analysis
Financial Health
Revenue Growth16.70%
Profit Margin33.53%
P/E Ratio14.1
ROE14.75%
ROA0.85%
P/B Ratio1.9
Op. Cash FlowCA$-26968000512
Industry P/E17.4
Technical Analysis
TrendBullish
RSI47.7
SupportCA$128.59
ResistanceCA$143.80
MA 20CA$135.00
MA 50CA$130.33
MA 200CA$113.62
MACDBearish
VolumeIncreasing
Fear & Greed Index75.89
Valuation
Target PriceCA$143.97
Upside/Downside8.33%
GradeUndervalued
TypeBlend
Dividend Yield3.16%
Risk Assessment
Beta0.42
Volatility22.99%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.